Call for Abstract

3rd Cancer Diagnostics & Treatment Conference, will be organized around the theme “Advancement of new techniques and toils in cancer diagnostics”

Cancer diagnostics 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cancer diagnostics 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Diagnostic testing involves tests and procedures to confirm the presence of disease and identify the correct tumor type, location, extent and stage. We use sophisticated diagnostic technology to pinpoint and evaluate tumors, and develop a personalized treatment plan.

  •  A review of health history.
  •  Physical examination.
  •  Laboratory tests (blood, urine, etc.)
  •  Biopsy.
  •  Imaging tests (X-ray, PET/CT, MRI, ultrasound, etc.)
  •  Nuclear medicine scans (bone scans, etc.)
  •  Endoscopy.
  •  Genetic tests.
  • Track 1-1A review of health history
  • Track 1-2Genetic tests
  • Track 1-3Endoscopy
  • Track 1-4Nuclear medicine scans (bone scans, etc.)
  • Track 1-5Imaging tests (X-ray, PET/CT, MRI, ultrasound, etc.)
  • Track 1-6Biopsy
  • Track 1-7Laboratory tests (blood, urine, etc.)
  • Track 1-8Physical examination.
  • Track 1-9Physical examination.
  • Track 1-10Genomic testing

Cancer Radiology: Radiation Oncology encompasses all aspects of research that impacts on the treatment of cancer using radiation. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. The Radiotherapy/radiation therapy is broadly segmented into Teleradiotherapy, Brachy-radiotherapy and Metabolic Radiotherapy. Nuclear medicine is a branch of medicine that uses radiation to provide information about the functioning of a person's specific organs or to treat disease. Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues.

  • Track 2-1Radiation Therapies & Techniques
  • Track 2-2Medical Imaging
  • Track 2-3Radiobiology
  • Track 2-4Nuclear Medicine
  • Track 2-5Radiation Physics
  • Track 2-6Curative Radiation Therapy

 A cancer biomarker is an element or procedure that indicates the presence of cancer in the body. A biomarker may be any molecule released by presence a tumor or a specific indication of the body to the presence of cancer. Cancer biomarkers are usually biological molecules found in blood, other body fluids, or tissues that are a sign of a normal or abnormal process, or of a condition or disease.

  • Track 3-1Genetic biomarkers
  • Track 3-2Pathological biomarkers
  • Track 3-3In silico biomarkers
  • Track 3-4Imaging biomarkers
  • Track 3-5Glycoprotein biomarkers

A biopsy is the removal of a small amount of tissue for examination under a microscope. Other tests can suggest that cancer is present, but only a biopsy can make a definite diagnosis

 

 

 

 

 

  • Track 4-1Fine needle aspiration biopsy
  • Track 4-2Core needle biopsy
  • Track 4-3Vacuum-assisted biopsy
  • Track 4-4Image-guided biopsy
  • Track 4-5Incisional biopsy
  • Track 4-6Excisional biopsy
  • Track 4-7Shave biopsy
  • Track 4-8Endoscopic biopsy
  • Track 4-9Bone marrow aspiration and biopsy

The use of nanotechnology in cancer treatment offers some exciting possibilities, including the possibility of destroying cancer tumors with minimal damage to healthy tissue and organs, as well as the detection  and elimination of cancer cells before they form tumors.

 

  • Track 5-1Diagnostic Methods
  • Track 5-2Drug Delivery
  • Track 5-3Heart Disease
  • Track 5-4Heart Disease
  • Track 5-5Nanorobots & Therapy Methods

Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment.

 

  • Track 6-1Cancer Therapy: Clinical
  • Track 6-2Personalized Medicine and Imaging
  • Track 6-3Cancer Therapy: Preclinical
  • Track 6-4Biology of Human Tumors

 

Cancer Vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.

 

 

  • Track 7-1
  • Track 7-2Oncoviruses
  • Track 7-3Oncolytic Viral Therapies
  • Track 7-4Therapeutic Cancer Vaccines
  • Track 7-5HPV & Hepatitis B vaccine
  • Track 7-6Personalised Cancer Vaccines

The significance and role of the human genome in the diagnosis and treatment of disease, they lay out the groundwork for precision or genomic medicine. In turn, immuno-oncology researches are changing the way we treat cancer by unleashing the immune system, and achieving better survival for many patients and cure for some. Covering latest advances in precision medicine, genomics and genetics for drug discovery application, cancer immuno-therapy, biomarkers and translational strategies in immune-oncology, Precision Medicine and Immuno-Oncology tracks will bring together uppermost experts from industry and academia to discuss emerging trends and solutions in order to provide the most up-to-date, scientifically sound care for patients with cancer and chronic diseases.

  • Track 8-1Immuno-oncology biomarkers and companion
  • Track 8-2NGS assay selection, Validation and compliance
  • Track 8-3Preclinical and translational immunooncology
  • Track 8-4Coverage advanced diagnostics

Immunotherapy is treatment that uses your body's own immune system to help fight cancer. Get information about the different types of immunotherapy and the types of cancer they are used to treat.

  • Track 9-1Monoclonal antibodies: which are drugs that are designed to bind to specific targets in the body. They can cause an immune response that destroys cancer cells
  • Track 9-2Adoptive cell transfer: which is a treatment that attempts to boost the natural ability of your T cells to fight cancer. T cells are a type of white blood cell and part of the immune system. Researchers take T cells from the tumor. They then isolate the T
  • Track 9-3Cytokines: which are proteins that are made by your body’s cells. They play important roles in the body’s normal immune responses and also in the immune system’s ability to respond to cancer. The two main types of cytokines used to treat cancer are
  • Track 9-4Treatment Vaccines: which work against cancer by boosting your immune system’s response to cancer cells. Treatment vaccines are different from the ones that help prevent disease.

Cancer is treated in several ways, depending on each person's medical condition and type of cancer. Common treatments involve chemotherapy and radiation therapy. Other treatments include surgery and biological therapies.

 

 

  • Track 10-1Radiation therapy
  • Track 10-2Immunotherapy
  • Track 10-3Chemotherapy
  • Track 10-4Hormone therapy
  • Track 10-5Blood and bone marrow transplant
  • Track 10-6Biologic therapy

Molecular diagnostics is prominent disruptive innovation in healthcare by the introduction of many tools that are having a profound impact on healthcare delivery. These include next-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing, point-of-care assays, and early cancer detection. Join industry leaders at the molecular diagnostics event to discuss recent developments and decipher how changes in regulation, reimbursement, and implementation guidelines will impact progress in new markets created by innovations in this technology.

 

  • Track 11-1Stem cell & regeneration
  • Track 11-2Molecular medicine, biology and pathology
  • Track 11-3NGS assay selection, validation and compliance
  • Track 11-4Coverage advanced diagnostics

Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening tests are some of the prime factors spurring the demand for screening tools across the world. In addition, rising awareness and supportive government initiatives are some additional factors that are anticipated to boost the growth of the sector during the forecast period.

A thorough and accurate cancer diagnosis is the first step in developing an individualized cancer treatment plan. When you first visit one of our hospitals, we will perform a complete array of diagnostic tests to accurately confirm your diagnosis and plan your individualized treatment.

As successful as researchers have been in using nanotechnology to address and solve many important questions in the laboratory, the ultimate measure of the field’s success lies in the translation of research discoveries to the clinic. Currently, multiple nanotechnology-enabled diagnostic and therapeutic agents are in clinical trials, and many more are nearing that goal.